Range
0.04 - 0.04
Vol / Avg.
0.1K/29.2K
Div / Yield
-
52 Wk
0.02 - 0.08
Mkt Cap
55.7M
Payout Ratio
-
Open
0.04
P/E
-
EPS
-0.01
Shares
1.5B
Outstanding
-
Total Float
-
Acerus Pharmaceuticals Corp is a specialty pharmaceutical company. Principally, it is engaged in the development, manufacture, marketing, and distribution of branded products in men's and women's health. The company markets its product under brand ESTRACE, NATESTO, GYNOFLOR and TEFINA. The ESTRACE brand markets in Canada and is for the symptomatic relief of menopausal symptoms. Its NATESTO is a licensed nasal gel technology for replacement therapy in adult males diagnosed with hypogonadism. GYNOFLOR offers ultra-low dose vaginal estrogen therapy. Its TEFINA brand product is a low-dose nasal testosterone gel treatment in development for female sexual dysfunction.

Related Companies

TickerCompanyChg %Mkt Cap
ASPCFAcerus Pharmaceuticals2.94%55.7M

Acerus Pharmaceuticals Company Questions & Answers

Q

How do I buy Acerus Pharmaceuticals (ASPCF) stock?

A

You can purchase shares of Acerus Pharmaceuticals (OTC: ASPCF) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Acerus Pharmaceuticals's (ASPCF) main competitors?

A

There are no as such competitors for Acerus Pharmaceuticals.

Q

What is the target price for Acerus Pharmaceuticals?

A

There is no analysis for Acerus Pharmaceuticals

Q

How much is Acerus Pharmaceuticals (ASPCF) stock ?

A

The stock price for Acerus Pharmaceuticals (OTC: ASPCF) is $0.036234 last updated Today at 1:30:04 PM.

Q

When is the next Acerus Pharmaceuticals (ASPCF) dividend?

A

There are no upcoming dividends for Acerus Pharmaceuticals.

Q

When is Acerus Pharmaceuticals (OTC:ASPCF) reporting earnings?

A

There are no earnings for Acerus Pharmaceuticals

Q

When is the upcoming split for ASPCF?

A

There is no upcoming split for Acerus Pharmaceuticals.